You are now leaving a non-prescription product website and entering a prescription only product website.
At SkinMedica®, we believe everyone deserves to have naturally radiant skin. That's why we've dedicated years of research to formulating advanced skin care products that rejuvenate skin.
Our entire aesthetic product line is based on the science of the skin's own healing abilities. As skin ages, elasticity decreases, lines appear and overall appearance is diminished. To counteract the effects of time, our skin care products contain restorative ingredients that work below the skin's surface to regenerate the health of the skin.
Our scientifically proven recovery compounds include essential ingredients ranging from vitamins C and E to retinol to TNS®, our patented blend of growth factors, soluble collagen, antioxidants and matrix proteins. The impact is clear - fine lines are reduced, age spots and discoloration fade, and skin texture and elasticity is improved. All results of our commitment to creating a lifelong skin care solution for healthier skin.
From diverse strengths come important new therapies that make a real difference.
Allergan is a global, technology-driven multi-specialty health care company pursuing therapeutic advances to help patients live life to their fullest potential. In making this commitment, we work to develop an unparalleled level of insight into patients' wants and needs — and into the priorities and concerns of the medical specialists who treat them. To this end, we employ more than 50 percent of our work force in either research and development (R&D) or sales, ensuring our efforts are focused on innovation and our customers.
Allergan's flagship franchises in eye care, neurosciences, medical dermatology and urologics are structured under the company's pharmaceutical business portfolio, Allergan Pharmaceuticals. This portfolio offers specialty physicians and their patients a wide range of treatments to help preserve and protect sight, reduce physical disability and enhance quality of life.
With the acquisition of Inamed Corporation in 2006, Allergan added breast aesthetics and dermal fillers to its business portfolio to create a world-leading medical aesthetics franchise. The acquisition also gained Allergan a leading product portfolio in obesity intervention that offers minimally invasive devices to help patients achieve sustained weight loss and reduce health risks associated with obesity. All of these products are now represented within the Allergan Medical corporate division.
With specialty product lines focused on high-growth markets, Allergan represents a new multi-specialty health care model for the future, where diversification and focus live together to offer physicians and patients best-in-class treatments and a robust pipeline for continuous innovation. Bolstered by an integrated R&D organization and global infrastructure, characteristics of some of the industry's largest pharmaceutical companies, Allergan also maintains a lean and efficient operation with solid growth prospects, like many smaller and more specialized organizations in the health care field. Allergan is large enough to command sufficient resources to address significant patient needs yet small enough for nimble execution. As we look to the future, we will continue to follow our R&D technologies into additional specialty areas and build a leadership presence of relevance to the doctors and patients we serve.